Drug Delivery Strategies For Oral Pediatric and Geriatric Products
Posted on August 17, 2022
Carsten Timpe, Technical R&D Expert Scientist
Angela Dischinger, Group Head in Formulation and Process Development Small Molecules Drug Product
F. Hoffmann La Roche, Basel (Switzerland)
Introduction The paradigm of past decades in pharmaceutical industry was mainly to focus on development of blockbuster drugs that fit to all kinds of different patients, independent from their ages, physiological and disease conditions, genetic differences. It took many decades from the early days o...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
